Methods for depleting RNA from nucleic acid samples
The invention relates to methods of depleting RNA from a nucleic acid sample. The RNA may be any RNA, including, but not limited to, rRNA, tRNA, and mRNA. The method is useful for depleting RNA from a nucleic acid sample obtained from a fixed paraffin-embedded tissue (FPET) sample. The method may also be used to prepare cDNA, in particular, a cDNA library for further analysis or manipulation.
1. A composition comprising:
(a) a mixture comprising a plurality of RNA molecules, comprising target and non-target RNA molecules;
(b) a multiplicity of DNA probes comprising a plurality of synthetic DNA oligonucleotides capable of selectively hybridizing to the target RNA molecules in the mixture to produce DNA-RNA hybrids, wherein the plurality of synthetic DNA oligonucleotides is capable of selectively hybridizing along the entire full length sequence of the target RNA molecules; and
(c) an RNase for cleaving the DNA-RNA hybrids, wherein the RNase is capable of degrading the target RNA molecules in the DNA-RNA hybrids,
wherein, in the composition, the plurality of synthetic DNA oligonucleotides of (b) is selectively hybridized along the entire full length sequence of the target RNA molecules of (a), and wherein the multiplicity of DNA probes comprises at least two probes complementary to RNA sequences that overlap one another.
2. The composition of claim 1 , wherein the target RNA molecules have a poly(A) tail.
3. The composition of claim 1 , wherein the target RNA molecules lack a poly(A) tail.
4. The composition of claim 3 , wherein the target RNA molecules lacking a poly(A) tail comprise ribosomal RNA (rRNA) or transfer RNA (tRNA).
5. The composition of claim 4 , wherein the target RNA molecules lacking a poly(A) tail comprise rRNA, and wherein the rRNA is eukaryotic rRNA.
6. The composition of claim 5 , wherein the eukaryotic rRNA comprises one or more of the following eukaryotic rRNAs: cytoplasmic 5S rRNA, cytoplasmic 5.8S rRNA, cytoplasmic 18S rRNA, cytoplasmic 28S rRNA, mitochondrial 12S rRNA or mitochondrial 18S rRNA.
7. The composition of claim 4 , wherein the target RNA molecules lacking a poly(A) tail comprise rRNA, and wherein the rRNA is prokaryotic rRNA.
8. The composition of claim 7 , wherein the prokaryotic rRNA comprises one or more of the following prokaryotic rRNAs: 5S rRNA, 16S rRNA, and 23S rRNA.
9. The composition of claim 1 , wherein the multiplicity of DNA probes comprises DNA probes that are not labeled with a reporter group moiety, an enzyme, or a ligand used for detection or confirmation of hybridization of the multiplicity of DNA probes to the target RNA sequence.
10. The composition of claim 1 , wherein the RNase is RNase H.
11. The composition of claim 1 , wherein the multiplicity of DNA probes are 10 to 100 nucleotides in length.
12. The composition of claim 11 , wherein the multiplicity of DNA probes are 14 to 85 nucleotides in length.
13. A composition comprising:
(a) a mixture comprising a plurality of RNA molecules, comprising target and non-target RNA molecules;
(b) a multiplicity of DNA probes comprising a plurality of synthetic DNA oligonucleotides capable of selectively hybridizing to the target RNA molecules in the mixture to produce DNA-RNA hybrids, wherein the plurality of synthetic DNA oligonucleotides is capable of selectively hybridizing along the entire full length sequence of the target RNA molecules; and
(c) an RNase for cleaving the DNA-RNA hybrids, wherein the RNase is capable of degrading the target RNA molecules in the DNA-RNA hybrids,
wherein, in the composition, the plurality of synthetic DNA oligonucleotides of (b) is selectively hybridized along the entire full length sequence of the target RNA molecules of (a), and wherein the multiplicity of DNA probes comprises at least two probes complementary to RNA sequences that overlap one another, and wherein the plurality of RNA molecules is obtained from a fixed paraffin-embedded tissue (FPET) sample.
14. The composition of claim 13 , wherein the target RNA molecules have a poly(A) tail.
15. The composition of claim 13 , wherein the target RNA molecules lack a poly(A) tail.
16. The composition of claim 15 , wherein the target RNA molecules lacking a poly(A) tail comprise ribosomal RNA (rRNA) or transfer RNA (tRNA).
17. The composition of claim 16 , wherein the target RNA molecules lacking a poly(A) tail comprise rRNA, and wherein the rRNA is eukaryotic rRNA.
18. The composition of claim 17 , wherein the eukaryotic rRNA comprises one or more of the following eukaryotic rRNAs: cytoplasmic 5S rRNA, cytoplasmic 5.8S rRNA, cytoplasmic 18S rRNA, cytoplasmic 28S rRNA, mitochondrial 12S rRNA or mitochondrial 18S rRNA.
19. The composition of claim 16 , wherein the target RNA molecules lacking a poly(A) tail comprise rRNA, and wherein the rRNA is prokaryotic rRNA.
20. The composition of claim 19 , wherein the prokaryotic rRNA comprises one or more of the following prokaryotic rRNAs: 5S rRNA, 16S rRNA, and 23S rRNA.
21. The composition of claim 13 , wherein the multiplicity of DNA probes comprises DNA probes that are not labeled with a reporter group moiety, an enzyme, or a ligand used for detection or confirmation of hybridization of the multiplicity of DNA probes to the target RNA sequence.
22. The composition of claim 13 , wherein the RNase is RNase H.
23. The composition of claim 13 , wherein the multiplicity of DNA probes are 10 to 100 nucleotides in length.
24. The composition of claim 13 , wherein the multiplicity of DNA probes are 14 to 85 nucleotides in length.